American Healthcare REIT, Inc. $AHR Shares Sold by KBC Group NV

KBC Group NV lowered its holdings in American Healthcare REIT, Inc. (NYSE:AHR) by 29.3% during the second quarter, Holdings Channel.com reports. The firm owned 4,890 shares of the company’s stock after selling 2,026 shares during the period. KBC Group NV’s holdings in American Healthcare REIT were worth $180,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. GAMMA Investing LLC increased its position in shares of American Healthcare REIT by 22.1% during the 2nd quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock worth $63,000 after purchasing an additional 311 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in American Healthcare REIT by 1.4% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 29,300 shares of the company’s stock worth $1,086,000 after buying an additional 393 shares during the period. Lion Street Advisors LLC boosted its stake in American Healthcare REIT by 6.2% during the second quarter. Lion Street Advisors LLC now owns 7,373 shares of the company’s stock worth $271,000 after buying an additional 430 shares during the period. Benjamin Edwards Inc. increased its position in shares of American Healthcare REIT by 3.2% during the first quarter. Benjamin Edwards Inc. now owns 14,368 shares of the company’s stock valued at $435,000 after acquiring an additional 444 shares during the last quarter. Finally, J.Safra Asset Management Corp raised its stake in shares of American Healthcare REIT by 8.3% in the 2nd quarter. J.Safra Asset Management Corp now owns 6,271 shares of the company’s stock valued at $226,000 after acquiring an additional 480 shares during the period. 16.68% of the stock is currently owned by hedge funds and other institutional investors.

American Healthcare REIT Price Performance

AHR stock opened at $49.47 on Thursday. The business’s 50-day moving average is $43.93 and its two-hundred day moving average is $39.80. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.44 and a quick ratio of 0.44. The firm has a market capitalization of $8.75 billion, a P/E ratio of 353.32, a P/E/G ratio of 2.05 and a beta of 0.98. American Healthcare REIT, Inc. has a 1 year low of $26.40 and a 1 year high of $50.51.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 17th. Investors of record on Tuesday, September 30th were paid a $0.25 dividend. The ex-dividend date was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.0%. American Healthcare REIT’s payout ratio is currently 714.29%.

Wall Street Analyst Weigh In

AHR has been the subject of a number of research analyst reports. Morgan Stanley reaffirmed an “overweight” rating and set a $52.00 price objective on shares of American Healthcare REIT in a research report on Monday. Scotiabank raised their price target on American Healthcare REIT from $47.00 to $55.00 and gave the stock a “sector outperform” rating in a research report on Thursday, November 13th. Truist Financial lifted their price objective on American Healthcare REIT from $44.00 to $46.00 and gave the company a “buy” rating in a research note on Tuesday, August 26th. Citigroup reiterated an “outperform” rating on shares of American Healthcare REIT in a report on Friday, October 17th. Finally, KeyCorp raised their target price on American Healthcare REIT from $43.00 to $55.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, American Healthcare REIT presently has an average rating of “Buy” and an average price target of $50.60.

Insider Activity at American Healthcare REIT

In related news, Director Jeffrey T. Hanson sold 20,010 shares of the stock in a transaction on Monday, November 10th. The stock was sold at an average price of $49.68, for a total value of $994,096.80. Following the transaction, the director owned 21,798 shares of the company’s stock, valued at $1,082,924.64. This represents a 47.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Mark E. Foster sold 3,850 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the sale, the executive vice president owned 59,100 shares in the company, valued at approximately $2,475,699. This represents a 6.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 25,360 shares of company stock valued at $1,229,398 in the last quarter. 0.92% of the stock is currently owned by company insiders.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.